Peer Review History

Original SubmissionNovember 30, 2025
Decision Letter - Eugenio Llorens, Editor

-->PONE-D-25-63719-->-->In vitro study of the growth, reproduction and pathogenicity responses of Fusarium oxysporum f. sp. zingiberi to autotoxins from ginger-->-->PLOS One

Dear Dr. Naicheng,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 14 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Eugenio Llorens

Academic Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following financial disclosure:

“This work was supported by grants from the Shandong Provincial Natural Science Foundation (grant number: ZR2023QC326) and Key R&D Program of Shandong Province,China (grant number: 2023TZXD028). Li received the first project and Xu received the second project.”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. We notice that your supplementary figures are uploaded with the file type 'Figure'. Please amend the file type to 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: No

Reviewer #2: Partly

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: Dear authors,

The article entitled “In vitro study of the growth, reproduction and pathogenicity responses of Fusarium oxysporum f. sp. zingiberi to autotoxins from ginger” resulted to me quite interesting well written but, the conclusions does not fit with the rsults presented and I am not according to them, this makes me to suggesting several poinst that might be improved after an extensive review of content, conclusions, discussion and some changes that might be useful to improve the scientific impact and general quality of the article and conclusions obtained.

Below I detailed my suggestions waiting that it will be useful.

Sincerely

Title

I would focus the title adjusting it to the main conclusions of the article, from my point of view I see much more relevant the founding about the effects of the different metabolites into the fungal metabolism so I would suggest this kind of title or similar:

Physiologic and molecular response of Fusarium oxysporum f. sp. zingiberi to ginger specific metabolites.”

I would suggest to author to review first my suggestion to understand this proposed title, based principally into the quite differences found between the effects produced by the different plant metabolites, more than the term autotoxins, considering that the specific effects of plant metabolites against high impact phytopathogens is poor and scarce known compared to other areas of knowledge.

Abstract

Considering making a big change into the structure and content of the abstract, check line 68 to 75 to present the results under this point of view, add all detailed results including FUB3 and FUB9 not included, highlight the role of cumarin but consider that it might be possible that the fungus is defending from cumarin effect, trying to not death and this might be the reason because you see the inhibition of mycelial growth but strong mycotoxin synthesis, because in plant the fungus try to eat death tissues and it likes a defense response of the fungus against coumarin more than that this metabolite acts as an autotoxin to promote Foz.

Explain also at the abstract in which the autotoxins are representative, but I would make a great effort for differentiate what is a fungal defense response against toxic and plant-defense-metabolites such as coumarin and derivates and which produce an effect of real autotoxin, which does not fit with current plant defense responses.

Lines 28-31.- make a fussion and shorter sentence which is repetitive.

Line 34-39.- consider change the conclusions accordingly to results.

Introduction

Lines 53-54.- detail, is there varieties, ecotypes with different resistances? Explain here.

Line 62.- cite roots here.

Lines 68-75.- consider add this part to abstract.

Line 82.- explain why coumarin inhibit plant growth? Or is just that coumarin is produced in response to the pathogen and plant stop the growth until defense mechanism are activated? Justify. Currently coumarin is produced as plant-defense metabolite.

Line 92.- the term “autotoxic exudades” means that the plant produces spontaneous cell death and currently this is associated with hypersensitive response, so I would try to present this as and HR produced in response for defense not to be “autotoxic”, the death with pathogens only has sense when this death stop the pathogen and save the plant.

Lines 95-98.- cite here why you used and selected them, why they come from leaves (see methods) and explain previous specific effects of all of them, here it is necessary to add the steps in wich those metabolites are produced by the plant during defense responses to Foz, check previous works including other plant systems and metabolomic studies made of plant systems responding to Foz and against Fol also and determine the sequence and kinetic about how those metabolites are produced by the plant. Probably the kinetic s coordinated and correlated with fungal vital cycle of infection and with penetration into the root.

Those points has to be considered along the work, as well as into results and conclusion and discussion section. Each metabolite has and specific effect on the fungus because attach the fungus at the different stages of plant-fungal colonization.

Line 106.- at this article indicates studies in leaves explain and justify in methods why use them.

Line 112.- Transform this table into text shorter because in all of them the times are the same.

Line 118.- add as follows:

Line 122.- why PDA ? how PDA interacts with metabolite structure? Did you check at controls?

Lines 156-173.- Did you check if inductions of those plant-genes CWDEs are related to production of certain metabolites ??? check and analyze and add to discussion.

Line 193.- Not all FUBs are cited into the abstract cite them with specific results. Why only FUB1 and UB3? Explain at discussion.

Line 197.- Why 7 days post treatment? Dis you make previous kinetics? Add and explain.

Line 210.- cite Livak et al., method for -2 landa CT QRT-PCR calculates.

Add here number of replicates and statistical “n” used.

Statistical

Specify at each case ANOVA, T-Test, number “n” in all figure legends applied.

Results

Lines 235, 252,264…etc: please cite at all sections each figure separately.

Line 280, lines 294-295., move to discussion, try to not put conclusions into results section.

Section 334

Consider here to conclude that the most toxic metabolites for the fungus are also inducing defense mycotoxins to stop plant defense response, there is a clear correlaction between the induction of FUBs produced by the metabolites and their toxic effects on fungal growth. Please consider this point of view.

Line 337.- consider add those data to abstract.

Line 350.- move to abstract and discuss those results.

Section 356 to 367:

This section is just the more important of the article giving very interesting conclusison for me more than that you explained.

A pathview program analysis is required to look for correlations between the kinetic of plant response production and metabolism and fungal gene induction and cycle of infection.

Consider moving to discussion section except to data obtained.

Here the results described about coumarin probably indicate that coumarin has in plant a direct toxic effect on the fungus reducing the mycelial growth and biomass according to the natural function of coumarin on roots and this very high toxic effect on fungal growth makes that the fungus try to protect itself by producing higher amounts of mycotoxins. This is a combat between not well considered at this section. Similar effects of hydroxycoumarin are according to that and analyze if synergistic effects of both metabolites has been described previously.

Please consider this point of view making the results of this work much more relevant.

Discussion

Lines 370 to 376.- consider for changing the abstract.

Line 379-381.- Consider that metabolite production is very expensive for the plant, and it will try first to stop the fungus but if this low concentration not work they produce higher quantities, at low concentrations if the compound are very toxic the fungus will try to survive attaching the plant, consider this “combat” at the discussion.

Line 398.- Correlate metabolite production at plants with pathview transcriptional previous data and metabolomics data responding to Fusarium sp.

Line 406.- Which are the natural concentrations in plants? Check and explain and discuss here.

Line 407-408.- consider that the activity of metabolites will be lower along the time because molecular stability and interaction with PDA medium ??

Lines 413 to 415.- explain clearly, this is not well understood. Explain differences between total biomass and mycelial, most of biomass Is mycelia? Explain. Increasing of mycelial might indicate the high toxic effect of the chemical and activation of fungal metabolism to survive?

Line 421.- explain in detail stimulating process of biomass production.

Lines 431.- consider the toxic direct effect of coumarin more than the autotoxicity and correspondence with expressions found in FoSir5 gene??

Lines 440 to 455.- Consider the defense responses of the fungus to survive to plant defense production of toxic metabolites associated to infection progress. Contrast your results with previous transcriptional and metabolomic studies made againt Fol and Foz previously, consider the kinetics of fungal penetration and kinetic of plant production of those different metabolites analyzed, I consider that probably you will find very interesting results.

Prepare only ONE scheme simpler with the hypothesis to add it into principal article discussion section.

Line 445.- Hydroxycoumarin does not like to contribute to fungal infection try to get different conclusions according to plant defense and plant-fungal combat. Justify in terms of interaction at nature not on plates. Highlight that PDA is not the same than soil interactions and results should not be extrapolated.

Line 474.- consider the protection role of coumarin against the fungus also inhibiting FA synthesis and add to abstract. One of the more interesting results are the coumarin role in plant defense please highlight this into abstract or including into the title.

Lines 486 to 491.- consider that plant is trying to survive attaching the fungus.

Plant metabolites activate cytotoxic fungal responses and for me this is one of the most important results shown at this work and this should be highlighted at title, abstract and conclusions.

Line 494.- Consider that this is on plates not at nature but highlight the role of those metabolites in plant for protecting against Foz more than increasing the incidence and plant autotoxicity.

Lines 500 to 503.- I am not according to these conclusions please review and consider changing the conclusions and point of view about very interesting results obtained.

Hoping to be useful

Sincerely

Reviewer #2: I have carefully reviewed the manuscript entitled “In vitro Study of the Growth, Reproduction, and Pathogenicity Responses of Fusarium oxysporum f. sp. zingiberi to Autotoxins from Ginger.” This study is relevant and of potential interest, as it demonstrates that four ginger-related autotoxins differentially affect the growth, reproduction, and virulence-associated traits of Fusarium oxysporum, thereby contributing to Fusarium wilt under long-term ginger monoculture. The work further provides mechanistic insight into how these autotoxins may influence disease development. Overall, the manuscript is within the scope of the journal. However, the presentation and writing of the manuscript require substantial improvement, and several important concerns should be addressed before the manuscript can be considered for publication

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1:Yes: Marta Berrocal-Lobo, Universidad Politécnica de Madrid

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

Attachments
Attachment
Submitted filename: PONE-D-25-63719_Review report.docx
Revision 1

Our detailed, point-by-point responses to each comment have been submitted under the document titled “Response to Reviewers.” Please find the separated file in our submission.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Eugenio Llorens, Editor

Physiologic and molecular response of Fusarium oxysporum f. sp. zingiberi to ginger autotoxins

PONE-D-25-63719R1

Dear Dr. Naicheng,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Eugenio Llorens

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: Dear authors,

The article entitled “In vitro study of the growth, reproduction and pathogenicity responses of Fusarium oxysporum f. sp. zingiberi to autotoxins from ginger” has been corrected accordingly with results and right conclusions now fit with them. I consider that all my suggestions were considered.

Reviewer #2: (No Response)

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1:Yes: Marta Berrocal-Lobo

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Eugenio Llorens, Editor

PONE-D-25-63719R1

PLOS One

Dear Dr. Li,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Eugenio Llorens

Academic Editor

PLOS One

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .